ResearchSpace

Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview

Show simple item record

dc.contributor.author Mkhabela, VJ
dc.contributor.author Ray, Suprakas S
dc.date.accessioned 2014-09-16T12:20:31Z
dc.date.available 2014-09-16T12:20:31Z
dc.date.issued 2014
dc.identifier.citation Mkhabela, V.J and Ray, S.S. 2014. Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview. Journal of Nanoscience and Nanotechnology, vol. 14(1), pp 535- 545 en_US
dc.identifier.issn 1533-4880
dc.identifier.uri http://hdl.handle.net/10204/7674
dc.description Copyright: 2014 American Scientific Publishers. This is an ABSTRACT ONLY. The definitive version is published in Journal of Nanoscience and Nanotechnology, vol. 14(1), pp 535- 545 en_US
dc.description.abstract Polycaprolactone is a bioresorbable polymer that has been extensively used in the biomaterials field and a number of drug-delivery systems. The superior rheological and viscoelastic properties of this polymer render it easy to manufacture and manipulate into a large range of medical devices and implants. The advantage of polycaprolactone over its aliphatic counterparts is that it has a long-term degradation period, which provides a good platform for the design and fabrication of implants that require long-term degradation kinetics for example in bone tissue engineering. The incorporation of nanofillers or blending of polycaprolactone with other polymers has yielded a class of hybrid materials with significantly improved physical and chemical properties such as strength, porosity, microstructure, controllable degradation rates, and bioactivity that are important for tissue engineering. This overview highlights the interesting advancements in polycaprolactone polymeric systems that relate to biological and tissue engineering applications, including aspects of technology in fabricating the scaffolds. en_US
dc.language.iso en en_US
dc.publisher American Scientific Publishers en_US
dc.relation.ispartofseries Workflow;13386
dc.subject Polycaprolactone en_US
dc.subject Nanocomposites en_US
dc.subject Scaffolds en_US
dc.subject Tissue engineering en_US
dc.title Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview en_US
dc.type Article en_US
dc.identifier.apacitation Mkhabela, V., & Ray, S. S. (2014). Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview. http://hdl.handle.net/10204/7674 en_ZA
dc.identifier.chicagocitation Mkhabela, VJ, and Suprakas S Ray "Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview." (2014) http://hdl.handle.net/10204/7674 en_ZA
dc.identifier.vancouvercitation Mkhabela V, Ray SS. Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview. 2014; http://hdl.handle.net/10204/7674. en_ZA
dc.identifier.ris TY - Article AU - Mkhabela, VJ AU - Ray, Suprakas S AB - Polycaprolactone is a bioresorbable polymer that has been extensively used in the biomaterials field and a number of drug-delivery systems. The superior rheological and viscoelastic properties of this polymer render it easy to manufacture and manipulate into a large range of medical devices and implants. The advantage of polycaprolactone over its aliphatic counterparts is that it has a long-term degradation period, which provides a good platform for the design and fabrication of implants that require long-term degradation kinetics for example in bone tissue engineering. The incorporation of nanofillers or blending of polycaprolactone with other polymers has yielded a class of hybrid materials with significantly improved physical and chemical properties such as strength, porosity, microstructure, controllable degradation rates, and bioactivity that are important for tissue engineering. This overview highlights the interesting advancements in polycaprolactone polymeric systems that relate to biological and tissue engineering applications, including aspects of technology in fabricating the scaffolds. DA - 2014 DB - ResearchSpace DP - CSIR KW - Polycaprolactone KW - Nanocomposites KW - Scaffolds KW - Tissue engineering LK - https://researchspace.csir.co.za PY - 2014 SM - 1533-4880 T1 - Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview TI - Poly( E-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview UR - http://hdl.handle.net/10204/7674 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record